The aim of this study was to investigate whether there are dermoscopic differences between BRAF-mutated and BRAFWT melanomas and whether dermoscopy can help differentiate between melanomas in situ (stage 0) and invasive thin melanomas (Breslow index ≤ 1 mm). The gene discussed is BRAF; the disease is melanoma.